Role of the NO‐cGMP pathway in the muscarinic regulation of the L‐type Ca2+ current in human atrial myocytes

G Vandecasteele, T Eschenhagen… - The Journal of …, 1998 - Wiley Online Library
G Vandecasteele, T Eschenhagen, R Fischmeister
The Journal of physiology, 1998Wiley Online Library
1 The whole‐cell patch‐clamp technique was used to examine the participation of nitric
oxide synthase (NOS) and soluble guanylyl cyclase in the muscarinic regulation of the L‐
type Ca2+ current (ICa) in freshly isolated human atrial myocytes. 2 Acetylcholine (ACh, 1
μM) decreased basal ICa by 39.1±5.5%(n= 8) under control conditions, and by
38.0±6.1%(n= 6) in the presence of 1H‐[1, 2, 4] oxadiazolo [4, 3‐a] quinoxaline‐1‐one
(ODQ, 10 μM), a potent guanylyl cyclase inhibitor, and NG‐monomethyl‐L‐arginine (L …
  • 1
    The whole‐cell patch‐clamp technique was used to examine the participation of nitric oxide synthase (NOS) and soluble guanylyl cyclase in the muscarinic regulation of the L‐type Ca2+ current (ICa) in freshly isolated human atrial myocytes.
  • 2
    Acetylcholine (ACh, 1 μM) decreased basal ICa by 39.1 ± 5.5 % (n= 8) under control conditions, and by 38.0 ± 6.1 % (n= 6) in the presence of 1H‐[1,2,4]oxadiazolo[4,3‐a]quinoxaline‐1‐one (ODQ, 10 μM), a potent guanylyl cyclase inhibitor, and NG‐monomethyl‐L‐arginine (L‐NMMA, 1 mM), a competitive NOS inhibitor. L‐NMMA alone had no effect on ICa, whilst ODQ increased ICa in 50 % of the cells.
  • 3
    The accentuated antagonism of ACh on ICa, i.e. its ability to antagonize the stimulatory effect of β‐adrenergic agonists and, by extension, of other cAMP‐elevating agents, was examined after the current was stimulated by either the β‐adrenergic agonist isoprenaline (Iso) or serotonin (5‐HT). ACh (100 nM or 1 μM) completely blocked the stimulatory effects of 10 nM Iso or 10 nM 5‐HT on ICa.
  • 4
    Extracellular application of Methylene Blue (MBlue, 10 μM), a guanylyl cyclase inhibitor, antagonized the inhibitory effect of 1 μM ACh on Iso‐ or 5‐HT‐stimulated ICa. However, this effect was overcome by a 100‐fold higher ACh concentration and was not mimicked by an intracellular application of MBlue.
  • 5
    Inhibition of NOS and soluble guanylyl cyclase activities by addition of ODQ (10 μM) and L‐NMMA (1 mM) to both extracellular and intracellular solutions, or by a 2 h pre‐incubation of the cells with these inhibitors, modified neither the Iso (10 nM) response nor the inhibitory effect of ACh (100 nM or 1 μM) on Iso‐stimulated ICa.
  • 6
    Extracellular application of the NO donor SNAP (S‐nitroso‐N‐acetyl‐D,L‐penicillamine) at 100 nM produced a stimulatory effect on ICa in control conditions. This stimulatory effect was abolished by intracellular MBlue (20 μM) or by intracellular and extracellular application of ODQ (10 μM) in combination with L‐NMMA (1 mM).
  • 7
    We conclude that the NO‐cGMP pathway does not contribute significantly to the muscarinic regulation of ICa in human atrial myocytes.
Wiley Online Library